Kehao Zhao

Co-founder, Chief Scientific Officer. Kehao brings more than 15 years of drug discovery experience in disease areas including cancer, liver disease, and ophthalmology. Before Elpis, Kehao was a senior investigator at Novartis Institutes for Biomedical Research leading antibody therapeutics platform and cancer epigenetics research. Previously, Kehao was a scientist at Procter & Gamble Pharmaceuticals. Kehao completed postdoctoral training in Gene Expression & Regulation at the Wistar Institute and received his Ph.D. from the Institute of Biophysics at the Chinese Academy of Sciences. Kehao has published over 30 research papers in prestigious scientific journals.